Long-term trajectory of postoperative health-related quality of life in young breast cancer patients: a 15-year follow-up study

Tran, Thi Xuan Mai; Jung, So‐Youn; Lee, Eun‐Gyeong; Cho, Heeyoun; Cho, Juhee; Lee, Eun-Sook; Chang, Yoon Jung; Cho, Hyunsoon

doi:10.1007/s11764-022-01165-4

Cited by 12 publications

(25 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This may be most applicable after at least 5 years post-surgery. 59,62]. This estimate had moderate certainty due to lack of consistency from large reliance on one study [59].…”

Section: Disutility Of An Interval Cancermentioning

confidence: 99%

“…The mean age across studies was 56.7 years (≥ 70 years in 4 studies [25,44,51,55]), and the total number of participants was 22,952 (range 30 to 8,287). Studies came from the Netherlands [29,[37][38][39][40][41]57], USA [25,26,35,53,55,58], South Korea [36,42,47,59], Finland [49,50,52,63], the United Kingdom [34,51,60], Australia [27,32,61], Japan [31,56], Spain [43,45], Norway [46], Italy [48], Croatia [62], Thailand [54], France [33], Greece [30], England…”

Section: Study Characteristicsmentioning

confidence: 99%

“…The disutility of adjuvant chemotherapy versus no chemotherapy may be 0.02 to 0.04 among a mixed surgical population within one year from surgery, due to concerns of inconsistency and indirectness from reliance for our estimate on between-study comparison data [34,36,41,44,45,49,51,52,56,59]. Subgroup analysis by type of adjuvant chemotherapy used was not possible due to insu cient reporting.…”

Section: Disutility Of An Interval Cancermentioning

confidence: 99%

“…Comparing adjuvant radiation use versus none within one year from surgery, there is probably little-to-no disutility among those receiving BCS/partial mastectomy or mastectomy, where many are also receiving adjuvant chemotherapy [25,27,31,32,34,45,50,56,[59][60][61]. The within-(disutility 0.01) and betweenstudy (HSUVs 0.80 vs. 0.81) analyses estimates were similar.…”

Section: Disutility Of An Interval Cancermentioning

confidence: 99%

See 3 more Smart Citations

Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care

Pillay,

Guitard,

Rahman

et al. 2024

Preprint

View full text Add to dashboard Cite

Background Different guideline panels, and individuals, may make different decisions based in part by their preferences. This systematic review update examined the relative importance placed by patients aged ≥ 35 years on the potential outcomes of breast-cancer screening. Methods We updated our searches to June 19, 2023 in MEDLINE, PsycINFO, and CINAHL. We screened grey literature, submissions by stakeholders, and reference lists. We sought three types of preferences, directly through i) utilities of screening and curative treatment health states (measuring the impact of the outcome on one’s health-related quality of life), and ii) other preference-based data, such as outcome trade-offs, and indirectly through iii) the relative importance of benefits versus harms inferred from attitudes, intentions, and behaviors towards screening among informed patients. For screening we used machine learning as one of the reviewers after at least 50% of studies had been reviewed in duplicate by humans; full-text selection used independent review by two humans. Data extraction and risk of bias assessments used a single reviewer with verification. Our main analysis for utilities used data from utility-based health-related quality of life tools (e.g., EQ-5D) in patients. When suitable, we pooled utilities and explored heterogeneity. Disutilities were calculated for screening health states and between different treatment states. Non-utility data were grouped into categories and synthesized with creation of summary statements. Certainty assessments followed GRADE guidance. Findings Eighty-two studies (38 on utilities) were included. The estimated disutilities were 0.07 for a positive screening result (moderate certainty), 0.03-0.04 for a false positive (FP; “additional testing” resolved as negative for cancer) (low certainty), and 0.08 for untreated screen-detected cancer (moderate certainty) or (low certainty) an interval cancer. At ≤12 months, disutilities of mastectomy (vs. breast-conserving therapy), chemotherapy (vs. none) (low certainty), and radiation therapy (vs. none) (moderate certainty) were 0.02-0.03, 0.02-0.04, and little-to-none, respectively. Over the longer term, there was moderate certainty for little-to-no disutility from mastectomy versus breast-conserving surgery/lumpectomy with radiation and from radiation. There was moderate certainty that a majority (>50%) and possibly large majority (>75%) of women probably accept up to six cases of overdiagnosis to prevent one breast-cancer death.Low certainty evidence suggested that a large majority may accept that screening may reduce breast-cancer but not all-cause mortality, at least when presented with relatively high rates of breast-cancer mortality reductions (n=2; 2 and 5 fewer per 1000 screened), and at least a majority accept that to prevent one breast-cancer death at least a few hundred patients will receive a FP result and 10-15 will have a FP resolved through biopsy. When using data from studies assessing attitudes, intentions, and screening behaviors, across all age groups but most evident for women in their 40s, preferences reduced as the net benefit presented by study authors decreased in magnitude. In a relatively low net-benefit scenario, a majority of patients in their 40s may not weigh the benefits as greater than the harms from screening (low certainty evidence). A large majority of patients aged 70-71 years probably think the benefits outweigh the harms for continuing to screen. A majority of women in their mid-70s to early 80s may prefer to continue screening. Conclusions Evidence across a range of data sources on how informed patients value the potential outcomes from breast-cancer screening will be useful during decision-making for recommendations. Further, the evidence supports providing easily understandable information on possible magnitudes of effects to enable informed decision-making. Systematic review registration: Protocol available at Open Science Framework https://osf.io/xngsu/

show abstract

“…This may be most applicable after at least 5 years post-surgery. 59,62]. This estimate had moderate certainty due to lack of consistency from large reliance on one study [59].…”

Section: Disutility Of An Interval Cancermentioning

confidence: 99%

Section: Study Characteristicsmentioning

confidence: 99%

Section: Disutility Of An Interval Cancermentioning

confidence: 99%

Section: Disutility Of An Interval Cancermentioning

confidence: 99%

See 2 more Smart Citations

Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care

Pillay,

Guitard,

Rahman

et al. 2024

Preprint

View full text Add to dashboard Cite

show abstract

“…After completing primary cancer treatment, patients with BC can continuously experience late and long-term treatment-related side effects such as pain, fatigue, obesity, limited movement in the upper limbs, muscle strength loss, lymphedema, and menopausal symptom. 4 , 5 , 6 , 7 Based on the available literature, 7%–52% of patients with BC have severe fatigue symptoms, and the strength in lower and upper extremities was reduced by 25% and 12%–16% compared with healthy women. 8 , 9 In addition, 68% and 74% of patients with BC gained weight and body fat within 1–3 years after diagnosis.…”

Section: Introductionmentioning

confidence: 99%

Effect of a telehealth-based exercise intervention on the physical activity of patients with breast cancer: A systematic review and meta-analysis

Peng¹,

Zhang²,

Wang³

et al. 2022

Asia-Pacific Journal of Oncology Nursing

View full text Add to dashboard Cite

Is it really over when it is over? physical, mental and emotional health status of long-term breast cancer survivors compared to healthy matched controls

Álvarez-Salvago,

Gutiérrez-García,

Molina-García

et al. 2024

Support Care Cancer

View full text Add to dashboard Cite

Long-term trajectory of postoperative health-related quality of life in young breast cancer patients: a 15-year follow-up study

Cited by 12 publications

References 47 publications

Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care

Patient preferences for breast cancer screening: a systematic review update to inform recommendations by the Canadian Task Force on Preventive Health Care

Effect of a telehealth-based exercise intervention on the physical activity of patients with breast cancer: A systematic review and meta-analysis

Is it really over when it is over? physical, mental and emotional health status of long-term breast cancer survivors compared to healthy matched controls

Contact Info

Product

Resources

About